Cargando…
Effect of Chronic Kidney Disease on Warfarin Management in a Pharmacist-Managed Anticoagulation Clinic
BACKGROUND: There is growing evidence that kidney disease affects hepatically cleared drugs. Accordingly, we hypothesized that chronic kidney disease (CKD) would disrupt anticoagulation of warfarin-treated patients and thereby increase the amount of management required to maintain appropriate antico...
Autores principales: | Kleinow, Megan E., Garwood, Candice L., Clemente, Jennifer L., Whittaker, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437548/ https://www.ncbi.nlm.nih.gov/pubmed/21870893 http://dx.doi.org/10.18553/jmcp.2011.17.7.523 |
Ejemplares similares
-
Outpatient management of chronic warfarin therapy at a pharmacist-run anticoagulation clinic during the COVID-19 pandemic
por: Cope, Rebecca, et al.
Publicado: (2021) -
Assessment of patients’ warfarin knowledge and anticoagulation control at a joint physician- and pharmacist-managed clinic in China
por: Li, Xingang, et al.
Publicado: (2018) -
Transportation Cost of Anticoagulation Clinic Visits in an Urban Setting
por: Hwang, Jamie M., et al.
Publicado: (2011) -
Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
por: Bahbahani, Hamad, et al.
Publicado: (2018) -
Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur
por: Ashouri, Feras, et al.
Publicado: (2011)